Skip to Content

100 Results Found

  • Review
  • Open Access
313 Views
15 Pages

The Role of MYBPC3 in Hypertrophic Cardiomyopathy

  • Olivia J. Harris and
  • Jason N. Dungu

Hypertrophic cardiomyopathy (HCM) is an inherited condition and one of the leading causes of sudden cardiac death in young individuals. It is primarily caused by the inheritance of pathogenic variants in sarcomere genes, including MYBPC3, encoding ca...

(This article belongs to the Special Issue An Updated View on Cardiomyopathies: Genetics, Imaging and Future Perspectives)
  • Review
  • Open Access
85 Citations
14,956 Views
17 Pages

An Update on MYBPC3 Gene Mutation in Hypertrophic Cardiomyopathy

  • Bogdan-Sorin Tudurachi,
  • Alexandra Zăvoi,
  • Andreea Leonte,
  • Laura Țăpoi and ,
  • Carina Ureche,
  • Silviu Gabriel Bîrgoan,
  • Traian Chiuariu,
  • Larisa Anghel,
  • Rodica Radu and
  • Cristian Stătescu
  • + 6 authors+ 1 author

Hypertrophic cardiomyopathy (HCM) is the most prevalent genetically inherited cardiomyopathy that follows an autosomal dominant inheritance pattern. The majority of HCM cases can be attributed to mutation of the MYBPC3 gene, which encodes cMyBP-C, a...

(This article belongs to the Collection Feature Papers in Molecular Genetics and Genomics)
  • Article
  • Open Access
6 Citations
4,855 Views
18 Pages

MYBPC3 D389V Variant Induces Hypercontractility in Cardiac Organoids

  • Darshini Desai,
  • Taejeong Song,
  • Rohit R. Singh,
  • Akhil Baby and ,
  • James McNamara,
  • Lisa C. Green,
  • Pooneh Nabavizadeh,
  • Mark Ericksen,
  • Sholeh Bazrafshan and
  • Sakthivel Sadayappan
  • + 6 authors+ 1 author

19 November 2024

MYBPC3, encoding cardiac myosin binding protein-C (cMyBP-C), is the most mutated gene known to cause hypertrophic cardiomyopathy (HCM). However, since little is known about the underlying etiology, additional in vitro studies are crucial to defining...

(This article belongs to the Section Stem Cells)
  • Article
  • Open Access
2 Citations
4,368 Views
27 Pages

Insights into the Novel Cardiac Biomarker in Acute Heart Failure: Mybp-C

  • Adriana Chetran,
  • Minerva Codruţa Bădescu,
  • Ionela Lăcrămioara Şerban,
  • Ştefania Teodora Duca and ,
  • Irina Afrăsânie,
  • Maria-Ruxandra Cepoi,
  • Bianca Ana Dmour,
  • Iulian Theodor Matei,
  • Mihai Ştefan Cristian Haba and
  • Irina Iuliana Costache-Enache
  • + 10 authors+ 5 authors

16 April 2024

(1) Background: Given its high cardiac specificity and its capacity to directly assess the cardiac function, cardiac myosin-binding protein (MyBP-C) is a promising biomarker in patients with acute heart failure (AHF). The aim of our study was to inve...

(This article belongs to the Section Physiology and Pathology)
  • Communication
  • Open Access
5 Citations
8,826 Views
11 Pages

Pathogenic Intronic Splice-Affecting Variants in MYBPC3 in Three Patients with Hypertrophic Cardiomyopathy

  • Katherine A. Wood,
  • Jamie M. Ellingford,
  • James Eden,
  • Huw B. Thomas and ,
  • Raymond T. O’Keefe,
  • Claire Hopton and
  • William G. Newman
  • + 2 authors+ 0 author

Genetic variants in MYBPC3 are one of the most common causes of hypertrophic cardiomyopathy (HCM). While variants in MYBPC3 affecting canonical splice site dinucleotides are a well-characterised cause of HCM, only recently has work begun to investiga...

(This article belongs to the Special Issue Cardiogenetics: Feature Papers 2021)
  • Article
  • Open Access
19 Citations
4,379 Views
12 Pages

Myocardial Deformation Analysis in MYBPC3 and MYH7 Related Sarcomeric Hypertrophic Cardiomyopathy—The Graz Hypertrophic Cardiomyopathy Registry

  • Viktoria Höller,
  • Heidelis Seebacher,
  • David Zach,
  • Nora Schwegel and ,
  • Klemens Ablasser,
  • Ewald Kolesnik,
  • Johannes Gollmer,
  • Gert Waltl,
  • Peter P. Rainer and
  • Nicolas Verheyen
  • + 7 authors+ 2 authors

23 September 2021

Accumulating evidence suggests that individuals with sarcomeric hypertrophic cardiomyopathy (HCM) carrying MYH7 mutations may have a worse prognosis than MYBPC3 mutation carriers. Myocardial deformation analysis is superior to standard echocardiograp...

(This article belongs to the Collection Genotype-Phenotype Study in Disease)
  • Article
  • Open Access
3 Citations
5,446 Views
14 Pages

Identification of Two Homozygous Variants in MYBPC3 and SMYD1 Genes Associated with Severe Infantile Cardiomyopathy

  • Marta W. Szulik,
  • Miguel Reyes-Múgica,
  • Daniel F. Marker,
  • Ana M. Gomez and ,
  • Matthew D. Zinn,
  • Leslie K. Walsh,
  • Juan Pablo Ochoa,
  • Sarah Franklin and
  • Lina Ghaloul-Gonzalez
  • + 4 authors+ 0 author

6 March 2023

Mutations in cardiac genes are one of the primary causes of infantile cardiomyopathy. In this study, we report the genetic findings of two siblings carrying variations in the MYBPC3 and SMYD1 genes. The first patient is a female proband exhibiting hy...

(This article belongs to the Section Human Genomics and Genetic Diseases)
  • Article
  • Open Access
65 Views
19 Pages

Background: Hypertrophic cardiomyopathy (HCM) is a genetically heterogeneous myocardial disorder in which variants in MYBPC3 represent a major genetic cause, although the functional significance of newly identified splice-region variants often remain...

(This article belongs to the Special Issue Hypertrophic Cardiomyopathy: Genetics, Mechanisms and Therapies)
  • Article
  • Open Access
1 Citations
3,954 Views
16 Pages

Description of a Cohort with a New Truncating MYBPC3 Variant for Hypertrophic Cardiomyopathy in Northern Spain

  • Natalia Fernández Suárez,
  • María Teresa Viadero Ubierna,
  • Jesús Garde Basas,
  • María Esther Onecha de la Fuente and ,
  • María Teresa Amigo Lanza,
  • Gonzalo Martin Gorria,
  • Adrián Rivas Pérez,
  • Luis Ruiz Guerrero and
  • Domingo González-Lamuño
  • + 4 authors+ 0 author

30 March 2023

Background: The pathogenicity of the different genetic variants causing hypertrophic cardiomyopathy (HCM) and the genotype/phenotype correlations are difficult to assess in clinical practice, as most mutations are unique or identified in non-informat...

(This article belongs to the Special Issue Genetics of Cardiovascular Metabolism)
  • Article
  • Open Access
18 Citations
4,755 Views
12 Pages

Untargeted Metabolomics Identifies Potential Hypertrophic Cardiomyopathy Biomarkers in Carriers of MYBPC3 Founder Variants

  • Mark Jansen,
  • Maike Schuldt,
  • Beau O. van Driel,
  • Amand F. Schmidt and ,
  • Imke Christiaans,
  • Saskia N. van der Crabben,
  • Yvonne M. Hoedemaekers,
  • Dennis Dooijes,
  • Jan D. H. Jongbloed and
  • Annette F. Baas
  • + 13 authors+ 8 authors

17 February 2023

Hypertrophic cardiomyopathy (HCM) is the most prevalent monogenic heart disease, commonly caused by pathogenic MYBPC3 variants, and a significant cause of sudden cardiac death. Severity is highly variable, with incomplete penetrance among genotype-po...

(This article belongs to the Special Issue Molecular Mechanisms of Cardiac Development and Disease)
  • Article
  • Open Access
707 Views
18 Pages

Clinical, Transcriptional and Haplotype Characterization of Recurrent MYBPC3 Splice-Site Variants c.1458-1G>A and c.3331-1G>A Associated with Hypertrophic Cardiomyopathy in Northern Italy

  • Carlotta Pia Cristalli,
  • Maria Alessandra Schiavo,
  • Miryam Rosa Stella Foti,
  • Sara Calabrese and ,
  • Federica Isidori,
  • Alice Margutti,
  • Pierluigi Laricchiuta,
  • Giulia Governatori,
  • Francesco Lai and
  • Cesare Rossi
  • + 25 authors+ 20 authors

28 July 2026

Background: Founder mutations in MYBPC3 may contribute substantially to the genetic burden of hypertrophic cardiomyopathy (HCM) and provide important insights into genotype–phenotype correlations and population-specific disease mechanisms. In t...

(This article belongs to the Section Molecular Genetics and Genomics)
  • Article
  • Open Access
7 Citations
4,563 Views
22 Pages

4 November 2021

Mutations in the gene encoding cardiac myosin-binding protein-C (MyBPC), a thick filament assembly protein that stabilizes sarcomeric structure and regulates cardiac function, are a common cause for the development of hypertrophic cardiomyopathy. Abo...

(This article belongs to the Special Issue The Physiology of Striated Muscle Tissues)
  • Case Report
  • Open Access
4 Citations
2,495 Views
12 Pages

Homozygous Pro1066Arg MYBPC3 Pathogenic Variant in a 26Mb Region of Homozygosity Associated with Severe Hypertrophic Cardiomyopathy in a Patient of an Apparent Non-Consanguineous Family

  • Raquel Rodríguez-López,
  • Javier García-Planells,
  • Marina Martínez-Matilla,
  • Cristian Pérez-García and ,
  • Amor García Banacloy,
  • Carola Guzmán Luján,
  • Otilia Zomeño Alcalá,
  • Joaquina Belchi Navarro,
  • Juan Martínez-León and
  • Rafael Salguero-Bodes
  • + 5 authors+ 0 author

12 July 2022

MYPBC3 and MYH7 are the most frequently mutated genes in patients with hereditary HCM. Homozygous and compound heterozygous genotypes generate the most severe phenotypes. A 35-year-old woman who was a homozygous carrier of the p.(Pro1066Arg) variant...

(This article belongs to the Special Issue Advances in Heart Disease)
  • Case Report
  • Open Access
5 Citations
3,997 Views
7 Pages

18 March 2021

Restrictive cardiomyopathy (RCM) is one of the rarest cardiac disorders, with a very poor prognosis, and heart transplantation is the only long-term treatment of choice. We reported that a Korean family presented different cardiomyopathies, such as i...

(This article belongs to the Section Genetics and Molecular Medicine)
  • Article
  • Open Access
6 Citations
6,804 Views
10 Pages

Mutations in MYBPC3 and MYH7 in Association with Brugada Type 1 ECG Pattern: Overlap between Brugada Syndrome and Hypertrophic Cardiomyopathy?

  • Marianna Farnè,
  • Cristina Balla,
  • Alice Margutti,
  • Rita Selvatici and ,
  • Martina De Raffele,
  • Assunta Di Domenico,
  • Paola Imbrici,
  • Elia De Maria,
  • Mauro Biffi and
  • Francesca Gualandi
  • + 8 authors+ 3 authors

9 September 2021

Brugada syndrome (BrS) is an inherited disorder with high allelic and genetic heterogeneity clinically characterized by typical coved-type ST segment elevation at the electrocardiogram (ECG), which may occur either spontaneously or after provocative...

(This article belongs to the Section Cardiovascular Genetics in Clinical Practice)
  • Article
  • Open Access
34 Citations
6,095 Views
13 Pages

Functional Studies and In Silico Analyses to Evaluate Non-Coding Variants in Inherited Cardiomyopathies

  • Giulia Frisso,
  • Nicola Detta,
  • Pamela Coppola,
  • Cristina Mazzaccara and ,
  • Maria Rosaria Pricolo,
  • Antonio D’Onofrio,
  • Giuseppe Limongelli,
  • Raffaele Calabrò and
  • Francesco Salvatore
  • + 4 authors+ 0 author

10 November 2016

Point mutations are the most common cause of inherited diseases. Bioinformatics tools can help to predict the pathogenicity of mutations found during genetic screening, but they may work less well in determining the effect of point mutations in non-c...

(This article belongs to the Special Issue Pre-mRNA Splicing 2016)
  • Review
  • Open Access
6 Citations
9,807 Views
15 Pages

Genetic Basis of Hypertrophic Cardiomyopathy in Cats

  • Arkadiusz Grzeczka,
  • Szymon Graczyk,
  • Robert Pasławski and
  • Urszula Pasławska

12 August 2024

Hypertrophic cardiomyopathy (HCM) is a common cardiovascular condition in cats, affecting yth males and females of all ages. Some breeds, such as Ragdolls and Maine Coons, can develop HCM at a young age. The disease has a wide range of progression an...

(This article belongs to the Section Biochemistry, Molecular and Cellular Biology)
  • Case Report
  • Open Access
12 Citations
1 Views
4 Pages

Familial Dilated Cardiomyopathy Associated with Congenital Defects in the Setting of a Novel VCL Mutation (Lys815Arg) in Conjunction with a Known MYPBC3 Variant

  • Quinn S. Wells,
  • Natalie L. Ausborn,
  • Birgit H. Funke,
  • Jean P. Pfotenhauer and ,
  • Joseph L. Fredi,
  • Samantha Baxter,
  • Thomas G. DiSalvo and
  • Charles C. Hong
  • + 3 authors+ 0 author

Idiopathic dilated cardiomyopathy (DCM) is a primary myocardial disorder characterized by ventricular chamber enlargement and systolic dysfunction. Twenty to fifty percent of idiopathic DCM cases are thought to have a genetic cause. Of more than 30 g...

  • Article
  • Open Access
7 Citations
6,825 Views
16 Pages

Hypertrophic cardiomyopathy (HCM), which is associated with thickening of the left ventricular wall, is one of the most common heart pathologies in cats. This disease has a hereditary etiology and is primarily related to mutations in the MYBPC3 and M...

  • Article
  • Open Access
1 Citations
3,887 Views
25 Pages

Hypertrophic cardiomyopathy (HCM) is among the most common forms of cardiomyopathies, with a prevalence of 1:200 to 1:500 people. HCM is caused by variants in genes encoding cardiac sarcomeric proteins, of which a majority reside in MYH7, MYBPC3, and...

(This article belongs to the Section Cardiovascular Genetics in Clinical Practice)
  • Article
  • Open Access
9 Citations
3,392 Views
20 Pages

4 November 2023

Hypertrophic cardiomyopathy (HCM) is a common inherited cardiac disorder characterized by marked clinical and genetic heterogeneity. Ethnic groups underrepresented in studies may have distinctive characteristics. We sought to evaluate the clinical an...

(This article belongs to the Special Issue Genetics of Human Cardiovascular Disease)
  • Article
  • Open Access
4 Citations
4,864 Views
15 Pages

Calcium-Dependent Interaction Occurs between Slow Skeletal Myosin Binding Protein C and Calmodulin

  • Tzvia I. Springer,
  • Christian W. Johns,
  • Jana Cable,
  • Brian Leei Lin and ,
  • Sakthivel Sadayappan and
  • Natosha L. Finley
  • + 1 author+ 0 author

Myosin binding protein C (MyBP-C) is a multi-domain protein that participates in the regulation of muscle contraction through dynamic interactions with actin and myosin. Three primary isoforms of MyBP-C exist: cardiac (cMyBP-C), fast skeletal (fsMyBP...

(This article belongs to the Special Issue Nuclear Magnetic Resonance Spectroscopy)
  • Article
  • Open Access
7 Citations
7,824 Views
18 Pages

Targeted Mybpc3 Knock-Out Mice with Cardiac Hypertrophy Exhibit Structural Mitral Valve Abnormalities

  • Daniel P. Judge,
  • Hany Neamatalla,
  • Russell A. Norris,
  • Robert A. Levine and ,
  • Jonathan T. Butcher,
  • Nicolas Vignier,
  • Kevin H. Kang,
  • Quangtung Nguyen,
  • Patrick Bruneval and
  • Albert A. Hagège
  • + 11 authors+ 6 authors

MYBPC3 mutations cause hypertrophic cardiomyopathy, which is frequently associated with mitral valve (MV) pathology. We reasoned that increased MV size is caused by localized growth factors with paracrine effects. We used high-resolution echocardiogr...

(This article belongs to the Special Issue Genetics and Cardiovascular Development and Disease)
  • Article
  • Open Access
892 Views
17 Pages

Association of Genetic Polymorphisms with Ischemic Sudden Cardiac Death: A Comparative Case–Control Study in North-Western Transylvania (Romania)

  • Daniela Cristina Pavel (Mironescu),
  • Costel Siserman,
  • Mihaela Laura Vică Matei,
  • Gheorghe Zsolt Nicula and ,
  • Ștefana Bâlici,
  • Bogdan-Alexandru Gheban,
  • Ioana-Andreea Gheban-Roșca,
  • Alexandra Șonfălean,
  • Denisa Jurje and
  • Horea-Vladi Matei
  • + 8 authors+ 3 authors

Background/Objectives: Ischemic sudden cardiac death (SCD) is a devastating event that often occurs in apparently healthy individuals. Genetic susceptibility may play a key role in the pathogenesis of such ischemic events. This study aimed to investi...

(This article belongs to the Special Issue Cardiovascular Diseases: From Pathophysiology to Novel Therapeutic Approaches, 2nd Edition)
  • Article
  • Open Access
1,389 Views
18 Pages

In this study, we have performed computational PTM analysis on a panel of hypertrophic cardiomyopathy (HCM)-associated proteins: MYH7, MYBPC3, TNNT2, and TNNI3. We aimed to benchmark the prediction of PTM sites of three ML-based tools: MusiteDeep, PT...

(This article belongs to the Section Molecular & Translational Genetics)
  • Review
  • Open Access
9 Citations
3,962 Views
16 Pages

Athletic performance is a multifactorial trait influenced by a complex interaction of environmental and genetic factors. Over the last decades, understanding and improving elite athletes’ endurance and performance has become a real challenge fo...

(This article belongs to the Special Issue Recent Advances in Sports Cardiology)
  • Article
  • Open Access
9 Citations
4,551 Views
20 Pages

Transcriptome Profile Identifies Actin as an Essential Regulator of Cardiac Myosin Binding Protein C3 Hypertrophic Cardiomyopathy in a Zebrafish Model

  • Sahar Isa Da’as,
  • Waseem Hasan,
  • Rola Salem,
  • Nadine Younes and ,
  • Doua Abdelrahman,
  • Iman A. Mohamed,
  • Arwa Aldaalis,
  • Ramzi Temanni,
  • Lisa Sara Mathew and
  • Khalid A. Fakhro
  • + 9 authors+ 4 authors

Variants in cardiac myosin-binding protein C (cMyBP-C) are the leading cause of inherited hypertrophic cardiomyopathy (HCM), demonstrating the key role that cMyBP-C plays in the heart’s contractile machinery. To investigate the c-MYBPC3 HCM-rel...

(This article belongs to the Special Issue Zebrafish as a Model in Human Disease)
  • Review
  • Open Access
1 Citations
2,665 Views
22 Pages

Revisiting the Genetics of Hypertrophic Cardiomyopathy: From Sarcomeres to Polygenic Modulation and Clinical Translation

  • Maria Cristina Carella,
  • Marco Maria Dicorato,
  • Paolo Basile,
  • Ilaria Dentamaro and ,
  • Daniela Santoro,
  • Eugenio Carulli,
  • Michele Davide Latorre,
  • Eduardo Urgesi,
  • Francesco Monitillo and
  • Cinzia Forleo
  • + 9 authors+ 4 authors

18 March 2026

Hypertrophic cardiomyopathy (HCM), the most common inherited cardiomyopathy, represents a paradigmatic condition for precision cardiovascular medicine. Once regarded as a monogenic autosomal dominant disorder driven by rare sarcomeric variants, HCM i...

(This article belongs to the Special Issue Advancements in Cardiomyopathies: Diagnosis, Treatment and Management—2nd Edition)
  • Brief Report
  • Open Access
1 Citations
2,048 Views
13 Pages

30 November 2024

The clinical significance of numerous cardiovascular gene variants remains to be determined. CRISPR/Cas9 allows for the introduction and/or correction of a certain variant in induced pluripotent stem cells (iPSCs). The resulting isogenic iPSC lines c...

(This article belongs to the Section Molecular Biology)
  • Case Report
  • Open Access
19 Citations
6,144 Views
6 Pages

Combined PTPN11 and MYBPC3 Gene Mutations in an Adult Patient with Noonan Syndrome and Hypertrophic Cardiomyopathy

  • Martina Caiazza,
  • Marta Rubino,
  • Emanuele Monda,
  • Annalisa Passariello and ,
  • Adelaide Fusco,
  • Annapaola Cirillo,
  • Augusto Esposito,
  • Anna Pierno,
  • Federica De Fazio and
  • Giuseppe Limongelli
  • + 9 authors+ 4 authors

17 August 2020

In this report, an atypical case of Noonan syndrome (NS) associated with sarcomeric hypertrophic cardiomyopathy (HCM) in a 33-year-old patient was described. Genetic testing revealed two different disease-causing mutations: a mutation in the PTPN11 g...

(This article belongs to the Special Issue Cardiovascular Genetics)
  • Case Report
  • Open Access
8 Citations
2,793 Views
9 Pages

Different Phenotypes of Sarcomeric MyBPC3-Cardiomyopathy in the Same Family: Hypertrophic, Left Ventricular Noncompaction and Restrictive Phenotypes (in Association with Sarcoidosis)

  • Olga Blagova,
  • Ekaterina Pavlenko,
  • Vsevolod Sedov,
  • Evgeniya Kogan and ,
  • Margarita Polyak,
  • Elena Zaklyazminskaya and
  • Yulia Lutokhina
  • + 2 authors+ 0 author

27 July 2022

The same variants in sarcomeric genes can lead to different cardiomyopathies within the same family. This gave rise to the concept of a continuum of sarcomeric cardiomyopathies. However, the manifestations and evolution of these cardiomyopathies in p...

(This article belongs to the Section Genetic Diagnosis)
  • Article
  • Open Access
7 Citations
3,411 Views
15 Pages

Echocardiography and MALDI-TOF Identification of Myosin-Binding Protein C3 A74T Gene Mutations Involved Healthy and Mutated Bengal Cats

  • Kanokwan Demeekul,
  • Pratch Sukumolanan,
  • Chattida Panprom,
  • Siriwan Thaisakun and ,
  • Sittiruk Roytrakul and
  • Soontaree Petchdee
  • + 1 author+ 0 author

12 July 2022

This study aimed to identify the potential peptide candidates and expected proteins associated with MYBPC3-A74T gene mutations in Bengal cats and determine if peptidome profiles differ between healthy controls and cats with MYBPC3-A74T gene mutations...

  • Article
  • Open Access
18 Citations
4,712 Views
12 Pages

The Genetic Architecture of Hypertrophic Cardiomyopathy in Hungary: Analysis of 242 Patients with a Panel of 98 Genes

  • Róbert Sepp,
  • Lidia Hategan,
  • Beáta Csányi,
  • János Borbás and ,
  • Annamária Tringer,
  • Eszter Dalma Pálinkás,
  • Viktória Nagy,
  • Hedvig Takács,
  • Dóra Latinovics and
  • István Nagy
  • + 16 authors+ 11 authors

Hypertrophic cardiomyopathy (HCM) is a primary disease of the myocardium most commonly caused by mutations in sarcomeric genes. We aimed to perform a nationwide large-scale genetic analysis of a previously unreported, representative HCM cohort in Hun...

(This article belongs to the Section Pathology and Molecular Diagnostics)
  • Review
  • Open Access
694 Views
24 Pages

Cardiac myosin-binding protein C (cMyBP-C) is a cardiac-restricted sarcomeric protein; after cardiomyocyte injury, circulating intact cMyBP-C and/or cMyBP-C fragments, collectively referred to here as the cMyC biomarker signal, appear rapidly in bloo...

(This article belongs to the Special Issue Molecular Mechanisms and Therapeutic Targets in Cardiovascular Health and Cardiotoxicity)
  • Article
  • Open Access
10 Citations
4,747 Views
18 Pages

Myosin Binding Protein-C Forms Amyloid-Like Aggregates In Vitro

  • Liya G. Bobyleva,
  • Sergey A. Shumeyko,
  • Elmira I. Yakupova,
  • Alexey K. Surin and ,
  • Oxana V. Galzitskaya,
  • Hiroshi Kihara,
  • Alexander A. Timchenko,
  • Maria A. Timchenko,
  • Nikita V. Penkov and
  • Alexander G. Bobylev
  • + 11 authors+ 6 authors

This work investigated in vitro aggregation and amyloid properties of skeletal myosin binding protein-C (sMyBP-C) interacting in vivo with proteins of thick and thin filaments in the sarcomeric A-disc. Dynamic light scattering (DLS) and transmission...

(This article belongs to the Special Issue Clearance, Degradation and Transport of Protein Aggregates)
  • Article
  • Open Access
7 Citations
5,043 Views
14 Pages

The C0-C1f Region of Cardiac Myosin Binding Protein-C Induces Pro-Inflammatory Responses in Fibroblasts via TLR4 Signaling

  • Athiththan Yogeswaran,
  • Christian Troidl,
  • James W. McNamara,
  • Jochen Wilhelm and ,
  • Theresa Truschel,
  • Laila Widmann,
  • Muhammad Aslam,
  • Christian W. Hamm,
  • Sakthivel Sadayappan and
  • Christoph Lipps
  • + 5 authors+ 0 author

26 May 2021

Myocardial injury is associated with inflammation and fibrosis. Cardiac myosin-binding protein-C (cMyBP-C) is cleaved by µ-calpain upon myocardial injury, releasing C0-C1f, an N-terminal peptide of cMyBP-C. Previously, we reported that the presence o...

(This article belongs to the Collection Cardiovascular Disease: From Molecular and Cellular Mechanisms to Therapeutic Opportunities)
  • Article
  • Open Access
1 Citations
1,288 Views
32 Pages

Cardiovascular and Clinical Manifestations of Marfan Syndrome and Other Inherited Connective Tissue Disorders with Coexisting Genetic Variants

  • Maria Elena Soto,
  • Gilberto Vargas-Alarcón,
  • Claudia Huesca-Gómez,
  • Israel Pérez-Torres and ,
  • José Antonio Arias-Godínez,
  • Sergio Enrique Meza-Toledo,
  • Regina de la Mora-Cervantes,
  • Hugo Rodríguez-Zanella,
  • Gabriela Meléndez-Ramírez and
  • Ricardo Gamboa
  • + 7 authors+ 2 authors

29 May 2026

Marfan syndrome (MS), Loeys–Dietz syndrome (LDS), Beals–Hecht syndrome (BHS), Ehlers–Danlos syndrome (EDS), and individuals with undifferentiated connective tissue disease (UCTD) exhibit phenotypic overlap, suggesting a likelihood o...

(This article belongs to the Collection Cellular and Molecular Pathophysiology of Vascular Proliferative Diseases)
  • Article
  • Open Access
11 Citations
4,516 Views
14 Pages

Application of Long-Read Nanopore Sequencing to the Search for Mutations in Hypertrophic Cardiomyopathy

  • Ramil R. Salakhov,
  • Maria V. Golubenko,
  • Nail R. Valiakhmetov,
  • Elena N. Pavlyukova and ,
  • Aleksei A. Zarubin,
  • Nadezhda P. Babushkina,
  • Aksana N. Kucher,
  • Aleksei A. Sleptcov and
  • Maria S. Nazarenko
  • + 4 authors+ 0 author

13 December 2022

Increasing evidence suggests that both coding and non-coding regions of sarcomeric protein genes can contribute to hypertrophic cardiomyopathy (HCM). Here, we introduce an experimental workflow (tested on four patients) for complete sequencing of the...

(This article belongs to the Special Issue State-of-the-Art Molecular Genetics and Genomics in Russia)
  • Brief Report
  • Open Access
3 Citations
1,569 Views
14 Pages

Pulsatile Myofilament Activity in Myotrem Myopathy Associated with Myogenic Tremor

  • Jennifer Megan Mariano,
  • Laurin M. Hanft,
  • Suhan Cho,
  • Christopher W. Ward and ,
  • Kerry S. McDonald and
  • Aikaterini Kontrogianni-Konstantopoulos
  • + 1 author+ 0 author

Myosin-binding protein C (MyBP-C) comprises a family of myofilament proteins that maintain sarcomeric structure and regulate actomyosin crossbridge cycling. Pathogenic variants in MYBPC1, the gene encoding the slow skeletal isoform (sMyBP-C), lead to...

(This article belongs to the Special Issue Sarcomeric Proteins in Health and Disease: 3rd Edition)
  • Article
  • Open Access
38 Citations
7,956 Views
23 Pages

Genetic Dissection of Hypertrophic Cardiomyopathy with Myocardial RNA-Seq

  • Jun Gao,
  • John Collyer,
  • Maochun Wang,
  • Fengping Sun and
  • Fuyi Xu

Hypertrophic cardiomyopathy (HCM) is an inherited disorder of the myocardium, and pathogenic mutations in the sarcomere genes myosin heavy chain 7 (MYH7) and myosin-binding protein C (MYBPC3) explain 60%–70% of observed clinical cases. The hete...

(This article belongs to the Section Molecular Genetics and Genomics)
  • Article
  • Open Access
1,828 Views
15 Pages

Cardiac Phase-Resolved T2* Magnetic Resonance Imaging Reveals Differences Between Normal Hearts and a Humanized Mouse Model of Hypertrophic Cardiomyopathy

  • Oumaima Laghzali,
  • Shahriar Shalikar,
  • Siqin Liu,
  • Sandra Lehmann and ,
  • Joao dos Santos Periquito,
  • Andreas Pohlmann,
  • Sonia Waiczies,
  • Lucie Carrier,
  • Hsin-Jung Yang and
  • Min-Chi Ku
  • + 6 authors+ 1 author

Background/Objectives: While T2* mapping effectively assesses cerebral blood oxygenation, its utility for capturing cardiac phase-dependent myocardial changes in hypertrophic cardiomyopathy (HCM) is underexplored. This study investigates T2* dynamics...

(This article belongs to the Special Issue Pathogenesis, Diagnosis, and Treatment of Cardiomyopathy)
  • Article
  • Open Access
2 Citations
2,367 Views
14 Pages

Hypertrophic Cardiomyopathy Genotype–Phenotype Analysis in Lithuanian Single-Center Cohort

  • Marius Šukys,
  • Eglė Ereminienė,
  • Kristina Aleknavičienė,
  • Rimvydas Jonikas and ,
  • Eglė Tamulėnaitė-Stuokė,
  • Joana Ažukaitė and
  • Rasa Ugenskienė
  • + 2 authors+ 0 author

25 December 2025

Hypertrophic cardiomyopathies (HCMs) are among the most common genetic disorders; however, they might be underdiagnosed. Sequencing core sarcomere gene panels remain the main diagnostic tool. We present the results of HCM genetic testing performed at...

(This article belongs to the Special Issue Molecular Studies of Monogenic Diseases: Diagnostics, Mechanisms and Therapeutics)
  • Article
  • Open Access
1 Citations
2,207 Views
17 Pages

Formation of an Amyloid-like Structure During In Vitro Interaction of Titin and Myosin-Binding Protein C

  • Tatiana A. Uryupina,
  • Liya G. Bobyleva,
  • Nikita V. Penkov,
  • Maria A. Timchenko and ,
  • Azat G. Gabdulkhakov,
  • Anna V. Glyakina,
  • Vadim V. Rogachevsky,
  • Alexey K. Surin,
  • Oxana V. Galzitskaya and
  • Alexander G. Bobylev
  • + 6 authors+ 1 author

Protein association and aggregation are fundamental processes that play critical roles in a variety of biological phenomena from cell signaling to the development of incurable diseases, including amyloidoses. Understanding the basic biophysical princ...

(This article belongs to the Special Issue Molecular and Neuromuscular Mechanisms in Skeletal Muscle Aging, 2nd Edition)
  • Communication
  • Open Access
11 Citations
5,714 Views
7 Pages

Effect of Expressions and SNPs of Candidate Genes on Intramuscular Fat Content in Qinchuan Cattle

  • Yaxing Li,
  • Gong Cheng,
  • Takahisa Yamada,
  • Jianfeng Liu and ,
  • Linsen Zan and
  • Bin Tong
  • + 1 author+ 0 author

7 August 2020

Marbling is characterized by the amount and distribution of intramuscular fat (IMF). The AKIRIN2, TTN, EDG1, and MYBPC1 genes are well-known marbling-related genes, which were first identified in Japanese Black beef cattle. The objectives of this stu...

(This article belongs to the Collection Advances in Cattle Breeding, Genetics and Genomics)
  • Article
  • Open Access
15 Citations
4,136 Views
17 Pages

Yield of Rare Variants Detected by Targeted Next-Generation Sequencing in a Cohort of Romanian Index Patients with Hypertrophic Cardiomyopathy

  • Miruna Mihaela Micheu,
  • Nicoleta-Monica Popa-Fotea,
  • Nicoleta Oprescu,
  • Stefan Bogdan and ,
  • Monica Dan,
  • Alexandru Deaconu,
  • Lucian Dorobantu,
  • Oana Gheorghe-Fronea,
  • Maria Greavu and
  • Maria Dorobanțu
  • + 9 authors+ 4 authors

7 December 2020

Background: The aim of this study was to explore the rare variants in a cohort of Romanian index cases with hypertrophic cardiomyopathy (HCM). Methods: Forty-five unrelated probands with HCM were screened by targeted next generation sequencing (NGS)...

(This article belongs to the Section Pathology and Molecular Diagnostics)
  • Article
  • Open Access
4 Citations
4,912 Views
13 Pages

Phospholamban p.Leu39* Cardiomyopathy Compared with Other Sarcomeric Cardiomyopathies: Age-Matched Patient Cohorts and Literature Review

  • Andreea Sorina Afana,
  • Laura Vasiliu,
  • Radu Sascău,
  • Robert Daniel Adam and ,
  • Cristina Rădulescu,
  • Sebastian Onciul,
  • Eliza Cinteză,
  • Adela Chirita-Emandi and
  • Ruxandra Jurcuț
  • + 4 authors+ 0 author

Hypertrophic cardiomyopathy (HCM) is a heterogeneous genetic disorder, most often caused by sarcomeric gene mutations, with a small proportion due to variants in non-sarcomeric loci. Phospholamban (PLN) is a phosphoprotein associated with the cardiac...

(This article belongs to the Section Cardiovascular Clinical Research)
  • Article
  • Open Access
13 Citations
3,903 Views
9 Pages

Different Phenotypes in Monozygotic Twins, Carriers of the Same Pathogenic Variant for Hypertrophic Cardiomyopathy

  • Manuel Rodríguez Junquera,
  • María Salgado,
  • Francisco González-Urbistondo,
  • Alberto Alén and ,
  • José Julián Rodríguez-Reguero,
  • Iria Silva,
  • Eliecer Coto,
  • Pablo Avanzas,
  • César Morís and
  • Rebeca Lorca
  • + 6 authors+ 1 author

30 August 2022

Hypertrophic cardiomyopathy (HCM) is a monogenic disease with autosomal dominant inheritance. Genotype–phenotype relationships are complex, with variable penetrance even within the same family. The involvement of other modulating genetic and en...

(This article belongs to the Special Issue Advances in Heart Disease)
  • Article
  • Open Access
7 Citations
3,067 Views
19 Pages

Cardiac MRI Strain as an Early Indicator of Myocardial Dysfunction in Hypertrophic Cardiomyopathy

  • Siqin Liu,
  • Oumaima Laghzali,
  • Shahriar Shalikar,
  • Mara-Camelia Rusu and ,
  • Lucie Carrier,
  • Thoralf Niendorf and
  • Min-Chi Ku
  • + 2 authors+ 0 author

7 February 2025

Hypertrophic cardiomyopathy (HCM) is often characterized by augmented cardiac contractility, which frequently remains undetectable in its early stages. Emerging evidence suggests that hypercontractility is linked to mitochondrial defects that develop...

(This article belongs to the Section Molecular Pathology, Diagnostics, and Therapeutics)
  • Article
  • Open Access
1 Citations
1,292 Views
14 Pages

Genetic Spectrum, Clinical Characteristics, and Molecular Pathogenesis of Hypertrophic Cardiomyopathy Requiring Heart Transplantation

  • Sofiya Andreeva,
  • Lyubov Korneva,
  • Mariya Marusova,
  • Yulia Sazonova and ,
  • Alexandra Gudkova,
  • Anna Streltsova,
  • Svetlana Fetisova,
  • Maria Simonenko,
  • Anna Fanta and
  • Anna Kostareva
  • + 13 authors+ 8 authors

Hypertrophic cardiomyopathy (HCM) progressing to end-stage heart failure and heart transplantation (HT) is a rare clinical scenario with an insufficiently explored genetic background. In this single-center retrospective cohort study, we aimed to char...

(This article belongs to the Special Issue Advancements in the Epidemiology, Diagnosis and Treatment of Hypertrophic Cardiomyopathy)
  • Article
  • Open Access
1 Citations
1,336 Views
21 Pages

Systemic Metabolic Rewiring in a Mouse Model of Left Ventricular Hypertrophy

  • Alexandra V. Schmidt,
  • Tharika Thambidurai,
  • Olivia D’Annibale,
  • Sivakama S. Bharathi and ,
  • Tim Wood,
  • Eric S. Goetzman and
  • Julian E. Stelzer
  • + 2 authors+ 0 author

17 October 2025

Left ventricular hypertrophy (LVH) refers to the pathological thickening of the myocardial wall and is strongly associated with several adverse cardiac outcomes and sudden cardiac death. While the biomechanical drivers of LVH are well established, gr...

(This article belongs to the Section Molecular Endocrinology and Metabolism)

of 2